Physicochemical Properties
| Molecular Formula | C20H23FN10O9P2S2.2NA |
| Molecular Weight | 716.53 |
| Exact Mass | 736.018 |
| CAS # | 2243079-36-7 |
| Related CAS # | IACS-8803 diammonium;IACS-8803;2095690-70-1 |
| PubChem CID | 171360943 |
| Appearance | White to off-white solid powder |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 20 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 46 |
| Complexity | 1180 |
| Defined Atom Stereocenter Count | 7 |
| SMILES | OC1([H])[C@@]2([H])CO[P@](O[C@@]3([H])[C@@H](F)[C@H](N4C=NC5=C(N=CN=C45)N)O[C@]3([H])CO[P@](S)(=O)O[C@@]1([H])[C@H](N1C=NC3=C(N=CN=C13)N)O2)(S)=O.[NaH] |
| InChi Key | RTFZBFRTZGEDLP-WCYZRWMMSA-L |
| InChi Code | InChI=1S/C20H23FN10O9P2S2.2Na/c21-9-13-8(38-19(9)30-5-28-10-15(22)24-3-26-17(10)30)2-36-42(34,44)40-14-12(32)7(1-35-41(33,43)39-13)37-20(14)31-6-29-11-16(23)25-4-27-18(11)31;;/h3-9,12-14,19-20,32H,1-2H2,(H,33,43)(H,34,44)(H2,22,24,26)(H2,23,25,27);;/q;2*+1/p-2/t7-,8-,9-,12?,13-,14-,19-,20-,41?,42?;;/m1../s1 |
| Chemical Name | disodium;(1R,6R,8R,9R,10R,15R,17R)-8,17-bis(6-aminopurin-9-yl)-9-fluoro-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-18-ol |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | Mice with bilateral B16-OVA melanomas have enhanced anticancer activity when administered intratumorally with IACS-8803 (10 µg)[1]. |
| References |
[1]. Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy. Bioorg Med Chem Lett. 2019 Oct 15;29(20):126640. |
Solubility Data
| Solubility (In Vitro) | H2O: 56.67 mg/mL (76.74 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (67.70 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.3956 mL | 6.9781 mL | 13.9561 mL | |
| 5 mM | 0.2791 mL | 1.3956 mL | 2.7912 mL | |
| 10 mM | 0.1396 mL | 0.6978 mL | 1.3956 mL |